Company intelligence / Profile preview

Impact Clinical Trials Accelerator

United States

Ownership: Private
Development stage: Other

Overview

Impact Clinical is a CRO that manages clinical trials across all major therapeutic areas from Phase I (first-in-human) to Phase III and post-marketing, supporting both small pilots and pivotal studies for sponsors. It does not develop or own the pipeline; instead, it provides end-to-end clinical trial execution, medical writing, and regulatory consulting for clients.

Therapeutic areas: CardiovascularImmunologyEndocrinologyPulmonologyInfectious DiseasesDermatologyOncology
Modalities: Monoclonal antibodyCAR-T cell therapyCheckpoint inhibitorCRISPR-based therapyAntibody-drug conjugateGene therapyOncolytic virus therapySmall moleculeRecombinant protein
Industry: Contract Research Organization

Partnerships

Numerous sponsor pharmaceutical, biotech, and device companies

Beyond the preview

Go deeper on Impact Clinical Trials Accelerator.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Impact Clinical Trials Accelerator.

Explore the full profile